Company / Profit Margin
Eton Pharmaceuticals, Inc. Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3.0%
FY2025
5-year range
-71717.9% / -3.0%
FY2021-FY2025
Trend
+93.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 7 years, ranging from -71717.9% in FY2022 to -3.0% in FY2025.
Based on SEC 10-K filings.
-3.0% in FY2025 with a 5-year CAGR of +1325.5%.
Improved from -8.9% to -3.0% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +71715.0pp
- 5-Year Change
- +1325.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 93.0% year-over-year.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.0% | +93.0% |
| FY2024 | -42.4% | -374.3% |
| FY2023 | -8.9% | +100.0% |
| FY2022 | -71717.9% | -3654.2% |
| FY2021 | -1910.3% | -43.8% |
| FY2020 | -1328.5% | +7.2% |
| FY2019 | -1431.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026